John Wiley & Sons, Inc., The American Society for Pharmacology and Experimental Therapeutics (ASPET) and the British Pharmacological Society (BPS) announced today their partnership to publish the new open access, peer-reviewed journal, Pharmacology Research & Perspectives, which will open for submissions in April 2013.
Pharmacology Research & Perspectives (PR&P) will publish original research, reviews and perspectives in all areas of preclinical and clinical pharmacology, therapeutics, education and related research areas. The journal will serve as the first fully open access journal for ASPET and BPS, and joins their combined portfolio of prestigious peer-reviewed subscription-based scientific journals, such as the Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, Molecular Pharmacology, British Journal of Pharmacology, and British Journal of Clinical Pharmacology.
Editor-in-Chief Dr. Michael J. Curtis obtained his PhD from the University of British Columbia and has been a Reader at King's College London since 1996. Dr. Curtis has extensive editorial experience, serving as Editor-in-Chief of the Journal of Pharmacological and Toxicological Methods and Reviews Editor of British Journal of Pharmacology, among other positions.
“The publication of Pharmacology Research & Perspectives puts the ASPET-BPS-Wiley alliance at the forefront of open access publishing in pharmacology. I am confident that Mike’s expertise and insight will ensure we are able to realise the full potential of this exciting opportunity,” said Professor Philip Routledge, BPS President.
“ASPET is pleased to be working with the British Pharmacological Society and Wiley to launch this exciting new open access journal. The journal builds on the long-standing excellence of the publications associated with the two scientific societies and we join enthusiastically with Wiley in this new endeavor that will provide additional options for scientists and a forum for new directions in the discipline of pharmacology,” commented James E. Barrett, Chair of ASPET’s Board of Publications Trustees.
Deborah Dixon, VP, Publishing Director, Wiley, added,“We are extremely pleased to be partnering with two prestigious organizations to publish this new open access journal in pharmacology. It will provide authors worldwide with a high quality publishing option that will be fast and efficient.”
All articles in PR&P will be published as fully open access under a Creative Commons License on Wiley Online Library and deposited in PubMed Central immediately upon publication. A publication fee will be payable by authors on acceptance of their articles. Authors affiliated with, or funded by, an organization that has a Wiley Open Access Account can publish without directly paying any publication charges.
The journal expects to publish its first issue in autumn 2013.
About The American Society for Pharmacology and Experimental Therapeutics (ASPET)
The American Society for Pharmacology and Experimental Therapeutics (ASPET), founded in 1908, is one of the premier scientific societies for pharmacologists in the world. ASPET members conduct basic and clinical pharmacological research in academia, industry, and government. ASPET members’ research efforts help develop new medicines and therapeutic agents to fight existing and emerging diseases. ASPET publishes four high-impact peer-reviewed journals (Journal of Pharmacology and Experimental Therapeutics, Pharmacological Reviews, Molecular Pharmacology, and Drug Metabolism and Disposition). The Society provides a variety of other important services to its more than 4,800 members worldwide including educational opportunities through meetings, public affairs advocacy, award opportunities, and much more.
About the British Pharmacological Society (BPS)
BPS is the primary UK learned society concerned with research into drugs and the way they work. Existing BPS journals are the British Journal of Pharmacology and the British Journal of Clinical Pharmacology, both of which are published online. BPS members work in academia, industry, regulatory agencies and the health services, and many are medically qualified. The Society covers the whole spectrum of pharmacology, including laboratory, clinical, and toxicological aspects. Clinical pharmacology is the medical specialty dedicated to promoting safe and effective use of medicines for patient benefit. Many clinical pharmacologists work as consultants in the NHS and many hold prominent positions in UK Universities.
About Wiley Open Access
Wiley Open Access (wileyopenaccess.com) provides authors wishing to publish their research open access with a range of high quality publications which meet the requirements of funding organizations and institutions where these apply. Wiley Open Access journals are supported by a network of high-quality journals and societies as well as internationally-renowned editorial board members.
Wiley (wiley.com) is a global provider of content-enabled solutions that improve outcomes in research, education, and professional practice. Our core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners.
Founded in 1807, John Wiley & Sons, Inc. (NYSE: JWa, JWb), has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace. Wiley's global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia.